Pharmacelsus
Market-leading early stage contract research organisation
Pharmacelsus, Germany´s market-leading early stage CRO, plans, organizes and realizes customized preclinical studies for more than 20 years. Our assays meet national and international regulatory demands while using our unique consultative approach to serve more than 120+ satisfied customers who rely on our expertise, experience and passion for science.
Hit–to–Lead & Lead Optimisation
The Pharmacelsus portfolio covers the complete drug discovery and development testing program for small molecules and peptides in vitro, in vivo, ex vivo as well as G(C)LP and non-GLP bioanalysis. Structural, physicochemical and functional characterization of Biopharmaceuticals (e.g. Antibodies, ADCs, etc.) complements our comprehensive portfolio.
GBA Group Pharma Sites
Preclinical Services
Science Park 2
66123 Saarbrücken
Germany
Preclinical Services
Pharmacelsus GmbH
Science Park 2
66123 Saarbrücken
Germany
Fax +49 681 3946 - 7511
Contact
Member of GBA Group Pharma since 2017.